Hytel 20 Tablet contains Telmisartan 20 mg, an angiotensin II receptor blocker (ARB) used primarily for the management of hypertension. Telmisartan works by selectively blocking the binding of angiotensin II to the AT1 receptor in vascular smooth muscle and the adrenal gland, thereby inhibiting vasoconstriction and aldosterone secretion. This leads to vasodilation, reduced peripheral resistance, and consequently, a decrease in blood pressure. Hytel 20 is indicated for the treatment of essential hypertension to reduce the risk of cardiovascular events such as stroke, myocardial infarction, and heart failure in patients at risk. The medication is generally well-tolerated, with common side effects including dizziness, headache, and fatigue. It is contraindicated in patients with hypersensitivity to Telmisartan or any component of the formulation, and caution is advised in patients with renal impairment or hepatic dysfunction. Hytel 20 should not be used during pregnancy due to the risk of fetal toxicity. Dosage should be individualized based on patient response, and regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. Patients are advised to adhere to prescribed lifestyle modifications alongside pharmacotherapy for optimal blood pressure control.